Again....you can't make this **** up.
View attachment 9342
The FDA and vaccine makers say they are confident that shots targeting Omicron subvariants will work safely.
www.wsj.com
The Food and Drug Administration is expected to authorize
new Covid-19 booster shots this week without a staple of its normal decision-making process: data from a study showing whether the shots were safe and worked in humans.
The shots, modified to target the
latest versions of the Omicron variant, won’t have finished testing in humans when the FDA makes its decisions.
Instead, the
agency plans to assess the shots using data from other sources such as research in mice, the profiles of the original vaccines and the performance of earlier iterations of boosters targeting older forms of Omicron.